| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.001 |